BackAida Pharmaceuticals Overview

Aida Pharmaceuticals Intangible Assets

Track Aida Pharmaceuticals's intangible assets ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$20.08M
↑ 114.18% YoYΔ $10.71M vs prior year quarter

Peer trimmed avg / median

Loading

Aida Pharmaceuticals Intangible Assets History

Loading

Aida Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

Aida Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aida Pharmaceuticals (AIDA) FAQ

Aida Pharmaceuticals (AIDA) currently reports a intangible assets of $20M as of September 2008. That compares with $9.4M in the prior-year period — up 114.2% year over year. Use the charts on this page to explore Aida Pharmaceuticals's intangible assets history and peer comparisons.

Aida Pharmaceuticals's intangible assets increased from $9.4M to $20M — a 114.2% year-over-year increase (period ending September 2008). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aida Pharmaceuticals reported $20M in intangible assets as of September 2008. That compares with $9.4M in the prior-year period — up 114.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aida Pharmaceuticals, and consider following AIDA for alerts when major investors trade the stock.